Cataract Surgery Outcomes in Patients With Axenfeld-Rieger Syndrome.

IF 2.1 3区医学 Q2 OPHTHALMOLOGY

Cornea Pub Date : 2025-09-03 DOI:10.1097/ICO.0000000000003991

Priyanka Sudanaboina, Somasheila I Murthy

{"title":"Cataract Surgery Outcomes in Patients With Axenfeld-Rieger Syndrome.","authors":"Priyanka Sudanaboina, Somasheila I Murthy","doi":"10.1097/ICO.0000000000003991","DOIUrl":null,"url":null,"abstract":"Purpose: To analyze the outcomes of phacoemulsification with intraocular lens (IOL) implantation in patients with Axenfeld-Rieger syndrome (ARS).Methods: This was a retrospective observational study. Patients with ARS who underwent cataract surgery and had a minimum postoperative follow-up of 6 weeks were included. Visual outcomes after cataract surgery and complications were evaluated in these patients.Results: All patients underwent uneventful cataract surgery. A total of 12 eyes of 11 patients were included, 6 males and 5 females. The mean age was 45.3 ± 10.5 years, and the mean follow-up period was 21.6 months. The mean best-corrected visual acuity (BCVA) preoperatively was 0.9 ± 0.3 Log MAR and postoperatively was 0.4 ± 0.3 LogMAR (P = 0.0043). Eleven patients had secondary glaucoma requiring surgical intervention in 6/12 eyes (50%). Two patients required Descemet stripping automated endothelial keratoplasty (DSAEK) postcataract surgery for corneal decompensation. No significant intraoperative complications occurred in these patients.Conclusions: Cataract surgery and intraocular lens implantation in patients with ARS is safe, but visual improvement depends on comorbid conditions.","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cornea","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/ICO.0000000000003991","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To analyze the outcomes of phacoemulsification with intraocular lens (IOL) implantation in patients with Axenfeld-Rieger syndrome (ARS).

Methods: This was a retrospective observational study. Patients with ARS who underwent cataract surgery and had a minimum postoperative follow-up of 6 weeks were included. Visual outcomes after cataract surgery and complications were evaluated in these patients.

Results: All patients underwent uneventful cataract surgery. A total of 12 eyes of 11 patients were included, 6 males and 5 females. The mean age was 45.3 ± 10.5 years, and the mean follow-up period was 21.6 months. The mean best-corrected visual acuity (BCVA) preoperatively was 0.9 ± 0.3 Log MAR and postoperatively was 0.4 ± 0.3 LogMAR (P = 0.0043). Eleven patients had secondary glaucoma requiring surgical intervention in 6/12 eyes (50%). Two patients required Descemet stripping automated endothelial keratoplasty (DSAEK) postcataract surgery for corneal decompensation. No significant intraoperative complications occurred in these patients.

Conclusions: Cataract surgery and intraocular lens implantation in patients with ARS is safe, but visual improvement depends on comorbid conditions.

查看原文本刊更多论文

Axenfeld-Rieger综合征患者白内障手术的结果。

目的：分析Axenfeld-Rieger综合征（ARS）患者超声乳化术联合人工晶状体植入术的疗效。方法：回顾性观察性研究。ARS患者接受白内障手术，术后随访时间至少为6周。评估这些患者白内障手术后的视力结果和并发症。结果：所有患者均顺利完成白内障手术。11例患者共12眼，男6眼，女5眼。平均年龄45.3±10.5岁，平均随访21.6个月。平均最佳矫正视力（BCVA）术前为0.9±0.3 LogMAR，术后为0.4±0.3 LogMAR （P = 0.0043）。11例患者有6/12只眼（50%）的继发性青光眼需要手术干预。2例患者需要Descemet剥离自动内皮角膜移植术（DSAEK）白内障手术后角膜失代偿。本组患者术中无明显并发症发生。结论：ARS患者白内障手术和人工晶状体植入术是安全的，但视力的改善取决于合并症。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cornea 医学-眼科学

CiteScore

5.20

自引率

10.70%

发文量

354

审稿时长

3-6 weeks

期刊介绍： For corneal specialists and for all general ophthalmologists with an interest in this exciting subspecialty, Cornea brings together the latest clinical and basic research on the cornea and the anterior segment of the eye. Each volume is peer-reviewed by Cornea''s board of world-renowned experts and fully indexed in archival format. Your subscription brings you the latest developments in your field and a growing library of valuable professional references. Sponsored by The Cornea Society which was founded as the Castroviejo Cornea Society in 1975.